Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal Diseases

被引:0
|
作者
Rakeeb Kureshi
Angela Zhu
Jikui Shen
Stephany Y. Tzeng
Leilani R. Astrab
Paul R. Sargunas
Jordan J. Green
Peter A. Campochiaro
Jamie B. Spangler
机构
[1] Johns Hopkins University School of Medicine,Department of Biomedical Engineering
[2] Johns Hopkins University,Department of Chemical & Biomolecular Engineering
[3] Johns Hopkins University School of Medicine,Department of Ophthalmology, The Wilmer Eye Institute
[4] Johns Hopkins University School of Medicine,Department of Neuroscience
[5] Johns Hopkins University School of Medicine,Translational Tissue Engineering Center
[6] Johns Hopkins University,Insititute for Nanobiotechnology
[7] Johns Hopkins University,Department of Materials Science & Engineering
[8] Johns Hopkins University School of Medicine,Department of Neurosurgery
来源
Cellular and Molecular Bioengineering | 2020年 / 13卷
关键词
Ocular neovascularization; Vascular endothelial growth factor receptor; Directed evolution; Affinity engineering; Nonviral gene therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:405 / 418
页数:13
相关论文
共 13 条
  • [1] Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal Diseases
    Kureshi, Rakeeb
    Zhu, Angela
    Shen, Jikui
    Tzeng, Stephany Y.
    Astrab, Leilani R.
    Sargunas, Paul R.
    Green, Jordan J.
    Campochiaro, Peter A.
    Spangler, Jamie B.
    CELLULAR AND MOLECULAR BIOENGINEERING, 2020, 13 (05) : 405 - 418
  • [2] Vascular endothelial growth factors in retinal and choroidal neovascular diseases
    Kinnunen, Kati
    Yla-Herttuala, Seppo
    ANNALS OF MEDICINE, 2012, 44 (01) : 1 - 17
  • [3] Targeting vascular endothelial growth factor using retinal gene therapy
    Chung, Sook H.
    Frick, Sonia L.
    Yiu, Glenn
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (15)
  • [4] Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor
    Jo, Dong Hyun
    Kim, Jin Hyoung
    Yu, Young Suk
    Lee, Tae Geol
    Kim, Jeong Hun
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 (05) : 784 - 791
  • [5] Potential Anti-Vascular Endothelial Growth Factor Therapies for Central Retinal Vein Occlusion
    Marta S. Figueroa
    Inés Contreras
    Drugs, 2012, 72 : 2063 - 2071
  • [6] Quantitative Structure-Activity Relationship and Molecular Docking of Artemisinin Derivatives to Vascular Endothelial Growth Factor Receptor 1
    Saeed, Mohamed E. M.
    Kadioglu, Onnf
    Seo, Ean-Jeong
    Greten, Henry Johannes
    Brenk, Ruth
    Efferth, Thomas
    ANTICANCER RESEARCH, 2015, 35 (04) : 1929 - 1934
  • [7] Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis
    Cheng, Shun-Yun
    Luo, Yongwen
    Malachi, Anneliese
    Ko, Jihye
    Su, Qin
    Xie, Jun
    Tian, Bo
    Lin, Haijiang
    Ke, Xiao
    Zheng, Qiang
    Tai, Phillip W. L.
    Gao, Guangping
    Punzo, Claudio
    HUMAN GENE THERAPY, 2021, 32 (13-14) : 649 - 666
  • [8] Outcomes in Retinal Vein Occlusions Presenting with Poor Visual Acuity Treated with Anti-Vascular Endothelial Growth Factor Therapy
    Light, Jacob G.
    Tian, Jing
    Wenick, Adam S.
    OPHTHALMOLOGY RETINA, 2021, 5 (09): : 888 - 900
  • [9] Role of Soluble Vascular Endothelial Growth Factor Receptor-1 and-2 in Regulating Branch Retinal Vein Occlusion with Macular Edema
    Xie, Pengliang
    Zheng, Lufang
    Dong, Mingxia
    Zhang, Huaiqiang
    Chen, Fang
    PAKISTAN JOURNAL OF ZOOLOGY, 2023, 55 (03) : 1339 - 1345
  • [10] HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells
    Lombardi, G.
    Calistri, A.
    Curtarello, M.
    Giudice, G. L.
    Piermarocchi, S.
    Prosdocimo, G.
    Palu, G.
    Parolin, C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (02) : 244 - 248